CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sonnet Biotherapeutics Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sonnet Biotherapeutics Holdings Inc
100 Overlook Center, Suite 102
Phone: (609) 375-2227p:609 375-2227 PRINCETON, NJ  08540  United States Ticker: CCLR CCLR
Business Summary
Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company. The Company's technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The Company designed the FHAB construct to improve drug accumulation in cancer tumors, as well as to extend the duration of activity in the body. Its lead asset, SON-1010, is a fully human single-chain version of Interleukin 12 (IL-12), covalently linked to the FHAB construct, for which it is pursuing clinical development in solid tumors. Its lead clinical-stage asset, SON-080, is a fully human version of IL-6 manufactured in Chinese Hamster Ovary (CHO) cells. SON-080, for its target indications of Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Diabetic Peripheral Neuropathy (DPN). Its pipeline also includes SON-1210, SON-1410 and SON-3015.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20239/30/2023YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer PankajMohan 59 4/1/2020 4/1/2020
Chief Financial Officer John H.Cross 52 4/1/2020 4/1/2020
Chief Scientific Officer John K.Cini 70 4/1/2020 4/1/2020
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
JUST FRESH RESTAURANT 127 N TRYON ST CHARLOTTE NC
American Roadside Burgers, Inc 440 S Church St Charlotte NC United States
SONNET BioTherapeutics, Inc. 100 Overlook Center Princeton NJ United States
Little Big Burger 122 Northwest 10th Ave. Portland OR United States
Spoon Bar and Kitchen 8220 Westchester Dr. Dallas TX United States

Business Names
Business Name
BGR Holdings, LLC
BGR: The Burger Joint
BURG
17 additional Business Names available in full report.

General Information
Number of Employees: 12 (As of 9/30/2023)
Outstanding Shares: 3,069,516 (As of 12/31/2023)
Shareholders: 76
Stock Exchange: NASD
Federal Tax Id: 202932652
Fax Number: (302) 636-5454
Email Address: invest@chanticleerholdings.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024